Bob D. Brown

2020

In 2020, Bob D. Brown earned a total compensation of $3.4M as Executive Vice President of R&D, Chief Scientific Officer at Dicerna Pharmaceuticals, a 57% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$209,925
Option Awards$1,882,576
Salary$466,500
Stock Awards$781,268
Other$19,468
Total$3,359,737

Brown received $1.9M in option awards, accounting for 56% of the total pay in 2020.

Brown also received $209.9K in non-equity incentive plan, $466.5K in salary, $781.3K in stock awards and $19.5K in other compensation.

Rankings

In 2020, Bob D. Brown's compensation ranked 3,461st out of 13,090 executives tracked by ExecPay. In other words, Brown earned more than 73.6% of executives.

ClassificationRankingPercentile
All
3,461
out of 13,090
74th
Division
Manufacturing
1,349
out of 5,621
76th
Major group
Chemicals And Allied Products
509
out of 2,254
77th
Industry group
Drugs
442
out of 1,954
77th
Industry
Pharmaceutical Preparations
331
out of 1,459
77th

Pay ratio

Bob D. Brown's Pay$3,359,737
Median Employee's Pay$311,375
Pay Ratio

11

to 1

In 2020, the annual total compensation of Bob D. Brown was $3,359,737.

The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.

The ratio of Bob D. Brown's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 20, 2021.

Brown's colleagues

We found six more compensation records of executives who worked with Bob D. Brown at Dicerna Pharmaceuticals in 2020.

2020

Douglas Fambrough

Dicerna Pharmaceuticals

Chief Executive Officer

2020

Ralf Rosskamp

Dicerna Pharmaceuticals

Chief Medical Officer

2020

John Green

Dicerna Pharmaceuticals

Chief Financial Officer

2020

James Weissman

Dicerna Pharmaceuticals

Chief Operating Officer

2020

Shreeram Aradhye

Dicerna Pharmaceuticals

Chief Medical Officer

2020

Douglas Pagán

Dicerna Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like